Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Tusa Rav Not Better Than Docetaxel for NSCLC
SAN DIEGO — The novel antibody-drug conjugate tusamitamab ravtansine (tusa rav, Sanofi) did not demonstrate greater efficacy than docetaxel in treating advanced nonsquamous non–small cell lung cancer (NSCLC), according to the final results of a study. These findings, which were…
English